Gaucher disease: resetting the clinical and scientific agenda.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Oncological Aspects of Lysosomal Storage Diseases.Cells · 2024
   Review
2. Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher Disease.Journal of clinical medicine · 2019
   Article
3. Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Advanced drug delivery reviews · 2017
   Review
4. Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.Critical reviews in oncogenesis · 2013
   Review
5. Gaucher's disease and cancer: a sphingolipid perspective.Critical reviews in oncogenesis · 2013
   Review
6. The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity?Transactions of the American Clinical and Climatological Association · 2013
   Review
7. Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.Blood · 2012
   Article
8. Imiglucerase in the treatment of Gaucher disease: a history and perspective.Drug design, development and therapy · 2012
   Review
9. Gaucher disease and cancer: concept and controversy.International journal of cell biology · 2011
   Article
10. Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.American journal of hematology · 2010
    Article

Corrections and comments

• Comment on
  Enzyme replacement therapy for mild patients with Gaucher disease.2009

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as